Suchergebnisse - "Voreloxin"

PubPharm (13)

1

1,8-Naphthyridine Derivatives : A Privileged Scaffold for Versatile Biological Activities

enthalten in: Mini reviews in medicinal chemistry | 2021

von Ojha, M. | Yadav, D. | Kumar, A. | +2

2

Combination of ERK2 inhibitor VX-11e and voreloxin synergistically enhances anti-proliferative and pro-apoptotic effects in leukemia cells

enthalten in: Apoptosis : an international journal on programmed cell death | 2019

von Jasek-Gajda, E. | Jurkowska, H. | Jasińska, M. | +2

3

Combination of ERK2 inhibitor VX-11e and voreloxin synergistically enhances anti-proliferative and pro-apoptotic effects in leukemia cells

enthalten in: Apoptosis | 2019

von Jasek-Gajda, E. | Jurkowska, H. | Jasińska, M. | +2

4

Combination of ERK2 inhibitor VX-11e and voreloxin synergistically enhances anti-proliferative and pro-apoptotic effects in leukemia cells

enthalten in: Apoptosis | 2019

von Jasek-Gajda, E. | Jurkowska, H. | Jasińska, M. | +2

5

Combination of ERK2 inhibitor VX-11e and voreloxin synergistically enhances anti-proliferative and pro-apoptotic effects in leukemia cells

enthalten in: Apoptosis | 2019

von Jasek-Gajda, E. | Jurkowska, H. | Jasińska, M. | +2

6

TAK-733, a Selective MEK Inhibitor, Enhances Voreloxin-induced Apoptosis in Myeloid Leukemia Cells

enthalten in: Anticancer research | 2018

von Jasek-Gajda, E. | Gajda, M. | Jasińska, M. | +2

7

Synthesis and in vitro antitumor activity of novel naphthyridinone derivatives : = Synthesis and in vitro antitumor activity of novel naphthyridinone derivatives

enthalten in: Chinese chemical letters | 2017-02-15

China Academic Journals (CAJ), B, 理工B(化学化工冶金环境矿业) = Chemistry/ Metallurgy/ Environment/ Mine Industry

von Xue-Dong Jia | Shuo Wang | Ming-Hua Wang | +5

8

Vosaroxin is a novel topoisomerase-II inhibitor with efficacy in relapsed and refractory acute myeloid leukaemia

enthalten in: Expert opinion on pharmacotherapy | 2015

von Hotinski, A. | Lewis, I. | Ross, D.

9

Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo

enthalten in: Cancer chemotherapy and pharmacology | 2010

von Scatena, C. | Kumer, J. | Arbitrario, J. | +4

10

Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo

enthalten in: Cancer chemotherapy and pharmacology | 2010

von Scatena, C. | Kumer, J. | Arbitrario, J. | +4